SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548233-13-000005
Filing Date
2013-02-13
Accepted
2013-02-13 14:11:15
Documents
9
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT Dec2012_10q.htm 10-Q 620896
2 EXHIBIT 31-1 ctix10qex31-1.htm EX-31 9179
3 EXHIBIT 32-1 ctix10qex32-1.htm EX-32 5673
  Complete submission text file 0001548233-13-000005.txt   4598951

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctix-20121231.xml EX-101.INS 563170
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctix-20121231.xsd EX-101.SCH 55369
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctix-20121231_cal.xml EX-101.CAL 29904
7 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT ctix-20121231_def.xml EX-101.DEF 246177
8 XBRL TAXONOMY LABEL LINKBASE DOCUMENT ctix-20121231_lab.xml EX-101.LAB 402279
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctix-20121231_pre.xml EX-101.PRE 326008
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 13601956
SIC: 2834 Pharmaceutical Preparations